Drug activity against Onchocerca gutturosa males in vitro: a model for chemotherapeutic research on onchocerciasis
- 1 December 1987
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Helminthology
- Vol. 61 (4) , 271-281
- https://doi.org/10.1017/s0022149x00010178
Abstract
An in vitro system for chemotherapeutic research using adult male Onchocerca gutturosa has been developed as a model for O. volvulus. Using a culture system consisting of medium MEM+10% heat inactivated foetal calf serum (IFCS)+LLCMK2 (monkey kidney) feeder cells in an atmosphere of 5% CO2 in air, we examined the effects of a range of antiparasitic drugs on worm motility. Ivermectin, levamisole, furapyrimidone, Mel W, chloroquine, metrifonate, flubendazole, amoscanate and the Ciba-Geigy compounds CGP 6140, CGP 20′376 and CGI 17658 either immobilized or significantly reduced motility levels at a concentration of 5x10−5M or less within a 7-day period. Worms were affected at very low concentrations by ivermectin (effective conc. to reduce motility levels to 50% of controls, 3.14x10−8M), levamisole (7.95x10−8M), CGP 6140 (8.87x10−9M) and CGP 20′376 (2.78x10−8M). Difficulties were experienced in accurately repeating the immotile endpoint for levamisole due to an inconsistent partial recovery of motility. Over a 7-day period diethylcarbamazine had little effect on motility levels, while suramin caused a slight increase in activity compared to controls at some timepoints. Subsequent experiments demonstrated some differences in drug efficacy depending on the presence or absence of serum and feeder cells in the culture system probably because of drug avidly binding to serum proteins. However, serum and cells were found to be essential ingredients of the culture system to maintain worms in good condition, indicating that new drugs should be evaluated both in the presence and absence of serum and cells. Comparisons were made between the responses of O. gutturosa and Brugia pahangi to certain drugs and these species were found to significantly differ in their sensitivities to ivermectin and a novel compound (Wellcome), indicating that Onchocerca parasites should be used wherever possible for compound identification and development intended for the treatment of onchocerciasis. The in vitro system described here, using male O. gutturosa, provides a basis for further research and a practical alternative to O. volvulus.Keywords
This publication has 10 references indexed in Scilit:
- Fasciola hepatica in vitro: increased susceptibility to fasciolicides in a defined serum-free mediumParasitology, 1987
- Optimization of culture conditions for the maintenance of Onchocerca gutturosa adult worms in vitroJournal of Helminthology, 1986
- Acetyicholinesterase secretion–a parameter for the interpretation of in vitro anthelmintic screensParasitology, 1986
- Evidence for the occurrence of respiratory electron transport in adult Brugia pahangi and Dipetalonema viteaeMolecular and Biochemical Parasitology, 1985
- ChemotherapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1984
- The mode of action of suramin on the filarial worm Brugia pahangiParasitology, 1983
- Diethylcarbamazine-Enhanced Activation of Complement by Intact Microfilariae of Dirofilaria immitis and Their In vitro ProductsJournal of Parasitology, 1982
- The chemotherapy of onchocerciasis VIIIPathogens and Global Health, 1982
- EVALUATION OF THE BOVINE - ONCHOCERCA-GIBSONI, ONCHOCERCA-GUTTUROSA MODEL AS A TERTIARY SCREEN FOR DRUGS AGAINST ONCHOCERCA-VOLVULUS IN MAN1979